The Role of Serum Markers and Uterine Artery Doppler in Identifying At-Risk Pregnancies
Section snippets
Normal Placental Development
The human embryo undergoes interstitial implantation by invading the maternal decidua at the blastocyst stage.3 Differentiation of the trophectoderm yields multiple cell lineages, including extravillous trophoblasts, which invade maternal spiral vessels to form a hemochorial placenta in which fetal trophoblasts are bathed directly by maternal blood.4 However, maternal blood flow in the spiral vessels is initially limited by endovascular plugs5 and early placental development occurs in a state
Overview
Maternal serum analytes provide minimally invasive tests of fetal and placental endocrine function as well as endothelial dysfunction. The failure of trophoblastic invasion may be related to dysregulated secretory activity of the trophoblasts; whereas, alteration in the surface layer of the syncytiotrophoblast may contribute to leakage of human chorionic gonadotropin (hCG) and alpha-fetoprotein (AFP) into maternal circulation.16, 17 Reduced placental size or defective syncytiotrophoblast
Uterine Artery Doppler
Failure of spiral artery remodeling as reflected by enhanced uterine artery resistance has been linked to adverse pregnancy outcomes.72, 73 Increased resistance to uterine artery blood flow can be measured noninvasively by Doppler studies of the myometrial segments of the uterine arteries (Fig. 1A). The indices used to quantify uterine artery resistance include systolic (S) to diastolic (D) velocity ratio (S/D), pulsatility index (PI), resistive index (RI), and early diastolic notching.
Multiparameter tests
Since none of the current single parameter tests are sufficiently predictive of adverse pregnancy outcomes, many investigators have attempted to improve the predictive value of tests by combining them.42, 45, 67, 71, 91, 92 The use of multiple parameters seeks to increase specificity and sensitivity by exploring the different disease pathways. Generally, abnormal uterine artery Doppler, a reflection of inadequate trophoblastic invasion, is combined with abnormal biomarkers presumably resulting
Summary and future perspectives
Measures of placental dysfunction have the potential to identify pregnancies at increased risk of adverse outcomes. At the present time, the ability of any single one to accurately predict these outcomes is poor. The use of first-trimester and second-trimester biochemical markers in combination with uterine artery Doppler shows the greatest potential for screening tools. Adequately powered prospective studies using standardized methodology are necessary to further evaluate the choice of
References (107)
- et al.
Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: the Boyd collection revisited
Am J Obstet Gynecol
(1999) - et al.
Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies
Am J Pathol
(2003) - et al.
Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia
Placenta
(2000) - et al.
Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy
Placenta
(2009) - et al.
Pathogenesis and genetics of pre-eclampsia
Lancet
(2001) - et al.
Preeclampsia: an endothelial cell disorder
Am J Obstet Gynecol
(1989) - et al.
Elevated circulating thrombomodulin in severe preeclampsia
Am J Obstet Gynecol
(1993) - et al.
High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone
Am J Obstet Gynecol
(1991) Current topic: pre-eclampsia and the placenta
Placenta
(1991)- et al.
Screening for placental insufficiency in high-risk pregnancies: is earlier better?
Placenta
(2008)
Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins
Am J Pathol
Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia
Am J Pathol
Trophoblastic oxidative stress and the release of cell-free feto-placental DNA
Am J Pathol
Plasma P-selectin is elevated in the first trimester in women who subsequently develop pre-eclampsia
BJOG
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial)
Am J Obstet Gynecol
Obstetric outcomes in women with elevated maternal serum human chorionic gonadotropin
Am J Obstet Gynecol
Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome(1)
Obstet Gynecol
Very low second-trimester maternal serum alpha-fetoprotein: association with high birth weight
Obstet Gynecol
Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome
Obstet Gynecol
Serum screening with Down’s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis
BMC Pregnancy Childbirth
ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase
Biochem Biophys Res Commun
Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
Am J Obstet Gynecol
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria
J Biol Chem
Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies
Am J Obstet Gynecol
A platelet membrane protein expressed during platelet activation and secretion. Studies using a monoclonal antibody specific for thrombin-activated platelets
J Biol Chem
PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes
Cell
Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances
Am J Obstet Gynecol
3-dimensional colour power angiography for staging human placental development
Lancet
Validation of placental vascular sonobiopsy for obtaining representative placental vascular indices by three-dimensional power Doppler ultrasonography
Placenta
Placental vascular sonobiopsy using three-dimensional power Doppler ultrasound in normal and growth restricted fetuses
Placenta
First trimester placental and myometrial blood perfusion measured by 3D power Doppler in normal and unfavourable outcome pregnancies
Placenta
Pre-eclampsia
Lancet
Birth weight in relation to morbidity and mortality among newborn infants
N Engl J Med
Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia
Biol Reprod
The developing human. Clinically oriented embryology
The pattern of interstitial trophoblastic invasion of the myometrium in early human pregnancy
Placenta
Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy
J Clin Endocrinol Metab
Intrauterine growth restriction, human placental development and trophoblast cell death
J Physiol
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study
JAMA
Evaluation of elevations in maternal serum alpha-fetoprotein: a review
Obstet Gynecol Surv
Platelets and the beginnings of preeclampsia
N Engl J Med
Association of first-trimester low PAPP-A levels with preterm birth
Prenat Diagn
The efficiency of first-trimester serum analytes and maternal characteristics in predicting fetal growth disorders
Am J Obstet Gynecol
Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia
Prenat Diagn
First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses
Ultrasound Obstet Gynecol
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery
Ultrasound Obstet Gynecol
First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death
Ultrasound Obstet Gynecol
Pregnancy-associated plasma protein A, free beta-hCG, nuchal translucency, and risk of pregnancy loss
Obstet Gynecol
Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth
J Clin Endocrinol Metab
Quad screen as a predictor of adverse pregnancy outcome
Obstet Gynecol
Cited by (29)
Serum markers in quadruple screening associated with adverse pregnancy outcomes: A case–control study in China
2020, Clinica Chimica ActaCitation Excerpt :Adverse maternal and fetal complications usually occur in the third trimester of pregnancy, but the underlying pathology is largely determined in the early stages of pregnancy, and this response is initially adaptive. However, it leads to extensive systemic endothelial dysfunction and an imbalance in circulating vasoactive factors [15]. Before clinical manifestations, changes in these serum markers can be used as predictors of adverse pregnancy outcomes.
Combined use of serum MCP-1/IL-10 ratio and uterine artery Doppler index significantly improves the prediction of preeclampsia
2017, Clinica Chimica ActaCitation Excerpt :Changes in these factors' plasma concentrations during pregnancy have been used as biomarkers for the prediction as well as early diagnosis of preeclampsia. It was reported that a combined use of biochemical markers with uterine artery Doppler in the second trimester could be an efficient screening tool for assessing the risk of preeclampsia [9]. The goal of this study is to characterize the changes of candidate circulating factors, monocyte chemotactic protein-1 (MCP-1, or CCL2) and IL-10, under preeclamptic conditions, and apply them alone or in combination with Doppler ultrasonography for the prediction of preeclampsia.
Diagnosis of pre-eclampsia and assessment of severity through examination of the placenta with acoustic radiation force impulse elastography
2016, International Journal of Gynecology and ObstetricsCitation Excerpt :For these reasons, it is very important to include the diagnosis and follow-up of pre-eclampsia in pregnancy tracking. Multiple serum markers (e.g. serum β-human chorionic gonadotropin and pregnancy-associated plasma protein A) combined with Doppler ultrasonography to evaluate the blood flow velocity in the maternal uterine artery have shown promise in the identification of patients at increased risk of pre-eclampsia [8,9]. However, these tests might not be sufficiently accurate in identifying patients at risk or those who already have this complication [10].
Pregnancy-associated plasma protein a (papp-a) and preeclampsia
2014, Advances in Clinical ChemistryCitation Excerpt :Recent papers have shown that Doppler ultrasonography is more accurate in the second trimester, but there are encouraging results for first trimester screening with a combination of biomarkers. Doppler ultrasonography is also the most predictive marker for preeclampsia, but current data do not support its use for routine screening [16,36–38]. These different results for the early versus late and low- versus high-risk populations suggest that preeclampsia may be a heterogeneous disease [37].
Toxicity assessment on trophoblast cells for some environment polluting chemicals and 17β-estradiol
2013, Toxicology in VitroCitation Excerpt :In most of the studies low β-hCG levels in early gestation have been associated to early fetal loss (Braunstein et al., 1978; Goetzl et al., 2004 and Goetzl, 2010; van Ravenswaaij et al., 2011). In contrast to the low levels of hCG in the first trimester, high levels in the second trimester have been linked to pregnancy complications such as preeclampsia, intrauterine growth restriction and preterm birth (Tuuli and Odibo, 2011; Towner et al., 2006). Even though it is difficult to translate the data obtained in vitro with the pathophysiological conditions, any effect on the concentration of β-hCG by external substances might result in problems during pregnancy.
Funding support: none.